1 / 50

CERTIFICATION OF (CLINICAL) INVESTIGATORS Prof. JanHasker G. Jonkman,

CERTIFICATION OF (CLINICAL) INVESTIGATORS Prof. JanHasker G. Jonkman, Ph.D., F.C.P., F.R.Q.A., R.Ph., Clinical Pharmacologist University of Groningen (NL) Professor Quality Management in Drug Research and Manufacturing Stichting Certificering Klinisch Wetenschappelijk Onderzoeker.

lloyd
Télécharger la présentation

CERTIFICATION OF (CLINICAL) INVESTIGATORS Prof. JanHasker G. Jonkman,

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CERTIFICATION OF (CLINICAL) INVESTIGATORS Prof. JanHasker G. Jonkman, Ph.D., F.C.P., F.R.Q.A., R.Ph., Clinical Pharmacologist University of Groningen (NL) Professor Quality Management in Drug Research and Manufacturing Stichting Certificering Klinisch Wetenschappelijk Onderzoeker

  2. CERTIFICATION OF (CLINICAL) INVESTIGATORS TABLE OF CONTENTS • General • History • Present Situation • Future • Conclusions

  3. CERTIFICATION OF (CLINICAL) INVESTIGATORS TABLE OF CONTENTS • General • History • Present Situation • Future • Conclusions

  4. GENERAL (1) Definition: • Certification is the official proof - in writing and confirmed by signature - of the presence of knowledge and the ability to perform

  5. GENERAL (2) A high quality clinical study has to be performed in accordance with: • Appropriate ethical standards • Appropriate medical standards • Appropriate scientific standards • Appropriate legal standards • Appropriate regulatory standards

  6. GENERAL (3) High quality clinical study data require Investigators with: • Superior medical professional knowledge and skills for the safe conduct of a clinical study • Solid knowledge of Good Research Practices for an ethical conduct of a clinical study

  7. GENERAL (4) Are required knowledge and skills present? (1) • Investigators sign Form 1572 (FDA) declaring that • they are qualified to conduct and • are fully responsible for all aspects of the clinical study

  8. GENERAL (5) Are required knowledge and skills present? (2) • There is examination of medical knowledge and professional skills but • There is no examination of knowledge and skills on clinical research (‘Good Research Practices’)

  9. GENERAL (6) ‘These are the issues clinical trial sitesare struggling with based on my inspections. But number one on the list is lack of GCP knowledge and training’ Mike M. Rashti, Food and Drug Administration, FDA, USA, 2006

  10. GENERAL (7) ‘The single most important step we could take to improve clinical trials….. is to make sure that those doing the research are qualified to do it’ Greg Koski, Former Director of Office of Human Research Protections, OHRP, USA, 2004

  11. GENERAL (8) ‘Heute ist die Durchführung Klinischer Prüfungen ohne Spezialkenntnisse gar nicht denkbar’ Dr. Med. Norbert Clemens, Bundesvorsitzender der Deutschen Gesellschaft für Pharmazeutische Medizin e.V. (DG PharMed, 2007)

  12. Source: The CenterWatch Monthly, November 2006

  13. Source: The CenterWatch Monthly, November 2006

  14. Source: The CenterWatch Monthly, November 2006

  15. GENERAL (9) Training - The Netherlands • University Groningen (+ University Utrecht) GUIDE - Course ‘Good Research Practices GCP/GLP’ (since 1993) • Post graduate course • also open to external professionals • Several commercial (in-house) courses

  16. Source: Good Clinical Practice Journal, September 2004, p19-22

  17. GENERAL (10) Definition: • Certification is the official proof - in writing and confirmed by signature - of the presence of knowledge and the ability to perform

  18. GENERAL (11) Reasons for Certification (1) • May improve safety of subjects • May improve quality data • Conveys a commitment to clinical research • Provides assurance to Sponsor, authorities, Medical Ethics Committees, study participants and editors of journals that investigator understands requirements of GCP etc.

  19. GENERAL (12) Reasons for Certification (2) • (Together with training): intellectual stimulation / professional development • Business advantage (for ‘commercial’ Investigators) (N.B. In The Netherlands the law requires that an investigator has a certificate in order to be allowed to perform animalexperiments; ‘Art. 9’)

  20. CERTIFICATION OF (CLINICAL) INVESTIGATORS TABLE OF CONTENTS • General • History • Present Situation • Future • Conclusions

  21. HISTORY (1) • USA • ACRP* (Association of Clinical Research Professionals) • 1992: certification of Clinical Research Co-ordinations (CRCs) • 1995: certification of Clinical Research Associates (CRAs) • 2002: certification of Physician Investigators (PI) • approximately 14.000 people certified * www.ACRPnet.org

  22. HISTORY (2) • USA • DIA* (Drug Information Association) • 2002: certification of Clinical Investigators • SOCRA** (Society of Clinical Research Associates) • 1995: certification of Clinical Research Professionals • AAPP (American Academy of Pharmaceutical Physicians) • APPI (Academy of Pharmaceutical Physicians and Investigators; until 2003: AAPP = American Academy of Pharmaceutical Physicians) • 2003: certification of Physician Investigators * www.diahome.org ** www.SOCRA.org

  23. HISTORY (3) • USA • 2006: • Certification programs of DIA and APPI have been consolidated with ACRP programme resulting in two new affiliates of ACRP: • Academy of Clinical Research Professionals(The Academy) for certification of non-physicians(CCRA = Certified Clinical Research Associate; CCRC = Certified Clinical Research Coordinator) • APPI for certification of physicians(CPI = Certified Physician Investigator)

  24. HISTORY (4) • USA • total number of certificates: approximately 17.500 of which physicians approximately 400

  25. HISTORY (5) • Europe • ACRP • ECCRT (European Centre for Clinical Research Training)

  26. HISTORY (6) • Germany • DG PharMed • The Netherlands • GUIDE* Graduate School for Drug Exploration Certificate ‘Good Research Practices GCP / GLP’ University of Groningen • Belgium • PHARMED** Post-graduate programme in pharmacology and pharmaceutical medicine (University Brussels) * www.rug.nl/guide or www.pharmadvices.com **ulb.ac.be/medicine/pharmedwww

  27. CERTIFICATION OF (CLINICAL) INVESTIGATORS TABLE OF CONTENTS • General • History • Present Situation • Future • Conclusions

  28. PRESENT SITUATION: THE NETHERLANDS (1) New initiative for e-learning / e-testing / certification GCP (1) • 2004: • Prof.Dr. JanHasker G. Jonkman, University of Groningen • Drs. Bert Harenberg, MediaVision, Laren

  29. PRESENT SITUATION: THE NETHERLANDS (2) New initiative for e-learning / e-testing / certification GCP (2) • 2005: • other founding members (‘Initiating Group’) • Dr. Helena van den Dungen (Dutch GCP Inspectorate) • Dr. Herman Pieterse (GCP Consultant) • Cecilia Huisman (ACRP; NVRV) • Dr. Philip Salden (Nefarma) • Dr. Rudolf van Olden (NVFG) • Drs. Pieter Guelen (ACRON) • completion of a printed ‘proposal’ entitled ‘GCP - The necessity of GCP-examination in The Netherlands’

  30. PRESENT SITUATION: THE NETHERLANDS (3) • 2006 (1): • verbal commitment CCMO (Dr. M. Kenter) • contacts with NFU (Nederlandse Federatie Universiteiten; UMCs) • intention for a cooperation to design an exam in line with requirements of NFU (subject: ‘Wet en Regelgeving’)

  31. PRESENT SITUATION: THE NETHERLANDS (4) • 2006 (2): • On November 09; Stichting Certificering Klinisch Wetenschappelijk Onderzoeker (Foundation for Certification of Clinical Researchers) • residence: • Assen • board: • Prof.Dr. J.H.G. Jonkman • Prof.Dr. R.A. de Zeeuw • Dr. R.W. van Olden

  32. PRESENT SITUATION: THE NETHERLANDS (5) Stichting CKWO: Objectives 1. a. To improve the quality of clinical research in The Netherlands as well as elsewhere b. To perform all actions that will be necessary to reach the above mentioned objective 2. a. To establish and maintain a system for certification of clinical researchers b. To establish a system for examination in order to reach this objective of certification 3. The Foundation is a non-profit organization

  33. PRESENT SITUATION: THE NETHERLANDS (6) • 2006 (3): • Start of Editiorial Board • prepare first three exams • extended with two members on behalf of the NFU • Dr. Mieke Trip (AMC) • Dr. A.J.M. Craen (UMCL) • Dr. Rudolf van Olden was replaced by Drs. Alexandra Smeur-van Andel

  34. PRESENT SITUATION: THE NETHERLANDS (7) Concept of exam: • ‘Learning by Testing’ • Each exam consists of different ‘test cases’ • A 3-minutes video of a ‘real life’ situation (during a clinical study) followed by 3-5 multiple choice questions (= ‘Testing’)When the answer is wrong, the right answer will be given by the computer (= ‘Learning’)

  35. PRESENT SITUATION: THE NETHERLANDS (8) The system of examination will fulfil the following requirements (1): • Individual training (‘Learning by Testing’) • Modular system with different test cases and different small certificates (‘deelcertificaten’), together forming the full certificate • Flexible system: large freedom for candidate to • choose modules in own order • choose time and place of examination

  36. PRESENT SITUATION: THE NETHERLANDS (9) The system of examination will fulfil the following requirements (2): • Test cases should be interesting and stimulating (motivating) • It should be able to test not only knowledge of rules and laws, but in particular to test ‘GCP-mentality’

  37. PRESENT SITUATION: THE NETHERLANDS (10) The system of examination will fulfil the following requirements (3): • 2007 • June: first ‘try-out’ of examination in University Medical Center Amsterdam (AMC) (with three different video’s / test cases)

  38. CERTIFICATION OF (CLINICAL) INVESTIGATORS TABLE OF CONTENTS • General • History • Present Situation • Future • Conclusions

  39. FUTURE (1) • Prepare a publicly available list of ‘Certified Clinical Researchers’ (open to the public including all stakeholders like: Sponsors, authorities, Medical Ethics Committees, potential study participants, editors of journals, etc.) • Obtain acknowledgement of the certificate by the authorities e.g.: comparable with title ‘Clinical Pharmacologist’ that is recognized in the WMO (‘Wet Medisch-Wetenschappelijk Onderzoek met Mensen’; ‘Law on Medical Research in Human Subjects’)

  40. FUTURE (2) • More extensive use of the facilities of the web for the examination • May be extension to other area of Clinical Research rather than only Good Clinical Practices • May be extension to web-based training in Good Research Practices (‘e-learning’) • Hopefully the certification contributes to further appreciation of The Netherlands as ‘clinical trial country’

  41. CERTIFICATION OF (CLINICAL) INVESTIGATORS TABLE OF CONTENTS • General • History • Present Situation • Future • Conclusions

  42. CONCLUSIONS (1) • Solid training in clinical research is of paramount importance • There are many deficiencies in the knowledge of several clinical researchers as far as ‘Good Research Practices’ concerns • The knowledge of the staff involved should be easily recognized by other stakeholders (Sponsors, authorities, Medical Ethics Committees, potential study participants, editors of journals, etc.)

  43. CONCLUSIONS (2) • All opportunities of ‘e-learning’ and ‘e-testing’ will be used for learning and examination • Higher quality of clinical research staff will increase the attractiveness of The Netherlands as clinical trial country

More Related